Vimta Labs Q2 Results
- BSE: 524394
- NSE: VIMTALABS
- ISIN: INE579C01029
- Sector: Biotechnology & Drugs
BSE
465.45
-22.70 (-4.65%)
-22.70 (-4.65%)Volume9.08 K
Updated: Fri 13 Feb, 2026 | 15:29:26
NSE
463-27.70 (-5.64%)
-27.70 (-5.64%)Volume2.15 L
Updated: Fri 13 Feb, 2026 | 15:25:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Vimta Labs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 77.86 | 73.74 | 5.59% | 63.13 | 23.33% |
| Depreciation/ Amortization | 10.24 | 9.86 | 3.83% | 8.29 | 23.55% |
| Operating Income | 23.99 | 23.83 | 0.68% | 21.61 | 11.00% |
| Net Income | 19.92 | 18.89 | 5.43% | 15.25 | 30.65% |
| Other Operating Expenses Total | 18.86 | 17.25 | 9.34% | 12.55 | 50.25% |
| Net Income Before Taxes | 26.27 | 25.26 | 4.01% | 21.89 | 20.02% |
| Total Revenue | 101.85 | 97.56 | 4.39% | 84.74 | 20.19% |
| Selling/ General/ Admin Expenses Total | 28.61 | 27.82 | 2.86% | 23.94 | 19.51% |
| Diluted Normalized EPS | 4.44 | 4.21 | 5.46% | 3.77 | 17.71% |